403 related articles for article (PubMed ID: 33294299)
1. Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
Wang B; Huang Y
Oncoimmunology; 2020 Sep; 9(1):1824646. PubMed ID: 33294299
[TBL] [Abstract][Full Text] [Related]
2. Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data.
Park R; Lee SA; Kim SY; de Melo AC; Kasi A
Acta Oncol; 2021 Jan; 60(1):13-19. PubMed ID: 33131376
[TBL] [Abstract][Full Text] [Related]
3. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
Lin Z; Chen J; Han S
Expert Rev Anticancer Ther; 2021 Sep; 21(9):1055-1066. PubMed ID: 33970745
[No Abstract] [Full Text] [Related]
4. The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants.
Wu Q; Luo S; Xie X
BMC Cancer; 2022 Mar; 22(1):241. PubMed ID: 35246063
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19.
Yekedüz E; Utkan G; Ürün Y
Eur J Cancer; 2020 Dec; 141():92-104. PubMed ID: 33130550
[TBL] [Abstract][Full Text] [Related]
6. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
Gao Y; Chen Y; Liu M; Niu M; Song Z; Yan M; Tian J
Epidemiol Infect; 2021 Feb; 149():e66. PubMed ID: 33583450
[TBL] [Abstract][Full Text] [Related]
7. An observational study of hospitalized COVID-19 patients with cancer in San Diego county.
Hermel DJ; Cham J; Spierling Bagsic SR; Hong LK; Costantini CL; Mason JR; Saven A; Sigal DS
Future Oncol; 2022 Feb; 18(6):719-725. PubMed ID: 35105156
[TBL] [Abstract][Full Text] [Related]
8. Severity of COVID-19 in patients with lung cancer: evidence and challenges.
Passaro A; Bestvina C; Velez Velez M; Garassino MC; Garon E; Peters S
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737345
[TBL] [Abstract][Full Text] [Related]
9. Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis.
Cao C; Gan X; Hu X; Su Y; Zhang Y; Peng X
Aging (Albany NY); 2022 Mar; 14(5):2062-2080. PubMed ID: 35271463
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
Yarza R; Bover M; Paredes D; López-López F; Jara-Casas D; Castelo-Loureiro A; Baena J; Mazarico JM; Folgueira MD; Meléndez-Carmona MÁ; Reyes A; Lumbreras C; Paz-Ares L; Díaz-Pedroche C; Gómez-Martín C
Eur J Cancer; 2020 Aug; 135():242-250. PubMed ID: 32586724
[TBL] [Abstract][Full Text] [Related]
11. Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana.
Lunski MJ; Burton J; Tawagi K; Maslov D; Simenson V; Barr D; Yuan H; Johnson D; Matrana M; Cole J; Larned Z; Moore B
Cancer; 2021 Jan; 127(2):266-274. PubMed ID: 33112411
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis.
Yang Y; Cai Z; Zhang J
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33480978
[TBL] [Abstract][Full Text] [Related]
13. Association between recent oncologic treatment and mortality among patients with carcinoma who are hospitalized with COVID-19: A multicenter study.
Song K; Gong H; Xu B; Dong X; Li L; Hu W; Wang Q; Xie Z; Rao Z; Luo Z; Chu Q; Li F; Wang J
Cancer; 2021 Feb; 127(3):437-448. PubMed ID: 33136293
[TBL] [Abstract][Full Text] [Related]
14. Effect of antitumor therapy on cancer patients infected by SARS-CoV-2: A systematic review and meta-analysis.
Li P; Li L; Wang S; Liu Y; Li Z; Xia S
Cancer Med; 2021 Mar; 10(5):1644-1655. PubMed ID: 33547886
[TBL] [Abstract][Full Text] [Related]
15. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
16. Mortality of patients with COVID-19 who undergo an elective or emergency surgical procedure: a systematic review and meta-analysis.
Brown WA; Moore EM; Watters DA
ANZ J Surg; 2021 Jan; 91(1-2):33-41. PubMed ID: 33369009
[TBL] [Abstract][Full Text] [Related]
17. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis.
Wang Y; Chen B; Li Y; Zhang L; Wang Y; Yang S; Xiao X; Qin Q
J Med Virol; 2021 Mar; 93(3):1370-1377. PubMed ID: 33095513
[TBL] [Abstract][Full Text] [Related]
18. Obesity in COVID-19: A Systematic Review and Meta-analysis.
Ho JSY; Fernando DI; Chan MY; Sia CH
Ann Acad Med Singap; 2020 Dec; 49(12):996-1008. PubMed ID: 33463658
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
20. Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California.
Wu JT; Kwon DH; Glover MJ; Henry S; Wood D; Rubin DL; Koshkin VS; Schapira L; Shah SA
JCO Oncol Pract; 2021 Mar; 17(3):e377-e385. PubMed ID: 33332170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
